Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/10/2019
SIETES contiene 92824 citas

 
 
 1 a 20 de 34 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. An introduction to patient decision aids. Drug Ther Bull 2012;50:90-2. [Ref.ID 93521]
2.Tiene citas relacionadas
Gekas J, Gagné G, Bujold E, Douillard D, Forest JC, Reinharz D, Rousseau F. Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation. BMJ 2009;338:453-6. [Ref.ID 85332]
3.Tiene citas relacionadas Cita con resumen
Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A, Danish Fetal Medicine Research Group. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2009;338:449-52. [Ref.ID 85331]
4.Tiene citas relacionadas
Alfirevic Z. Prenatal screening for Down's syndrome. BMJ 2009;338:421-2. [Ref.ID 85320]
5. Cita con resumen
6. Cita con resumen
Dhallan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, Barry J, Betz J, Franz K, Gold K, Vallecillo B, Varney J. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 2007;369:474-81. [Ref.ID 79177]
7.Tiene citas relacionadas Cita con resumen
Caine A, Maltby AE, Parkin CA, Waters JJ, Crolla JA, for the UK Association of Clinical Cytogeneticists (ACC). Prenatal detection of Down's syndrome by rapìd aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment. Lancet 2005;366:123-8. [Ref.ID 74387]
8.Tiene citas relacionadas Cita con resumen
Leung W-C, Lao TT. Rapid aneuploidy testing, traditional karyotyping, or both?. Lancet 2005;366:97-8. [Ref.ID 74379]
9. Cita con resumen
Philip J et al. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstet Gynecol 2004;103:1164-73. [Ref.ID 71058]
10.Tiene citas relacionadas Cita con resumen
Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86. [Ref.ID 51097]
11.Tiene citas relacionadas
Wilson RD, for the CEMAT Study Group. Safety and fetal outcome of early and midtrimester amniocentesis. Authors' reply. Lancet 1998;351:1435-6. [Ref.ID 38742]
12.Tiene citas relacionadas
Eiben B, Hammans W, Goebel R, Epplen JT. Safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998;351:1435. [Ref.ID 38741]
13.Tiene citas relacionadas
Saura R, Taine L, Guyon F, Mangione R, Horovitz J. Safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998;351:1434-5. [Ref.ID 38740]
14.Tiene citas relacionadas
Konje JC, de Chazal R, Abrams K, Taylor DJ. Safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998;351:1434. [Ref.ID 38739]
15.Tiene citas relacionadas
The Canadian Early and Mid-Trimester Amniocentesis Trial (CEMAT) Group. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998;351:242-7. [Ref.ID 36829]
16.Tiene citas relacionadas Cita con resumen
Whittle MJ. Early amniocentesis: time for a rethink. Lancet 1998;351:226-7. [Ref.ID 36823]
17. Cita con resumen
Sundberg K, Bang J, Smidt-Jensen S, Brocks V, Lundsteen C, Parner J, Keiding N, Philip J. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 1997;350:697-703. [Ref.ID 35338]
18.
Stranc LC, Hamerton JL. Chorionic villus sampling and early amniocentesis for prenatal diagnosis. Authors' reply. Lancet 1997;349:1396-7. [Ref.ID 32626]
19.
Johnson P. Chorionic villus sampling and early amniocentesis for prenatal diagnosis. Lancet 1997;349:1396. [Ref.ID 32625]
20.
Greenough A, Nicolaides K H. Chorionic villus sampling and early amniocentesis for prenatal diagnosis. Lancet 1997;349:1395-6. [Ref.ID 32624]
Seleccionar todas
 
 1 a 20 de 34 siguiente >>